These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 11551520)
1. Suppression of cytokine production and neural cell death by the anti-inflammatory alkaloid cepharanthine: a potential agent against HIV-1 encephalopathy. Okamoto M; Ono M; Baba M Biochem Pharmacol; 2001 Sep; 62(6):747-53. PubMed ID: 11551520 [TBL] [Abstract][Full Text] [Related]
2. Potent inhibition of HIV type 1 replication by an antiinflammatory alkaloid, cepharanthine, in chronically infected monocytic cells. Okamoto M; Ono M; Baba M AIDS Res Hum Retroviruses; 1998 Sep; 14(14):1239-45. PubMed ID: 9764907 [TBL] [Abstract][Full Text] [Related]
3. Preventive effects of a biscoclaurine alkaloid, cepharanthine, on endotoxin or tumor necrosis factor-alpha-induced septic shock symptoms: involvement of from cell death in L929 cells and nitric oxide production in raw 264.7 cells. Sakaguchi S; Furusawa S; Wu J; Nagata K Int Immunopharmacol; 2007 Feb; 7(2):191-7. PubMed ID: 17178386 [TBL] [Abstract][Full Text] [Related]
4. The effects of biscoclaurine alkaloid cepharanthine on mammalian cells: implications for cancer, shock, and inflammatory diseases. Furusawa S; Wu J Life Sci; 2007 Feb; 80(12):1073-9. PubMed ID: 17204293 [TBL] [Abstract][Full Text] [Related]
5. Anti-HIV-1 activity and structure-activity relationship of cepharanoline derivatives in chronically infected cells. Baba M; Okamoto M; Kashiwaba N; Ono M Antivir Chem Chemother; 2001 Sep; 12(5):307-12. PubMed ID: 11900350 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of the biscoclaurine alkaloid, cepharanthine, for a range of clinical conditions. Rogosnitzky M; Danks R Pharmacol Rep; 2011; 63(2):337-47. PubMed ID: 21602589 [TBL] [Abstract][Full Text] [Related]
7. Cepharanthine exerts antitumor activity on oral squamous cell carcinoma cell lines by induction of p27Kip1. Harada K; Supriatno ; Yamamoto S; Kawaguchi S; Yoshida H; Sato M Anticancer Res; 2003; 23(2B):1441-8. PubMed ID: 12820407 [TBL] [Abstract][Full Text] [Related]
8. Establishment of an in vitro assay system mimicking human immunodeficiency virus type 1-induced neural cell death and evaluation of inhibitors thereof. Okamoto M; Wang X; Debyser Z; De Clercq E; Baba M J Virol Methods; 2003 Mar; 108(2):195-203. PubMed ID: 12609687 [TBL] [Abstract][Full Text] [Related]
9. Cepharanthine Inhibits IFN-γ-Induced CXCL10 by Suppressing the JAK2/STAT1 Signal Pathway in Human Salivary Gland Ductal Cells. Aota K; Yamanoi T; Kani K; Azuma M Inflammation; 2018 Feb; 41(1):50-58. PubMed ID: 28879548 [TBL] [Abstract][Full Text] [Related]
10. Suppression of tumor necrosis factor alpha-induced matrix metalloproteinase 9 production in human salivary gland acinar cells by cepharanthine occurs via down-regulation of nuclear factor kappaB: a possible therapeutic agent for preventing the destruction of the acinar structure in the salivary glands of Sjögren's syndrome patients. Azuma M; Aota K; Tamatani T; Motegi K; Yamashita T; Ashida Y; Hayashi Y; Sato M Arthritis Rheum; 2002 Jun; 46(6):1585-94. PubMed ID: 12115190 [TBL] [Abstract][Full Text] [Related]
11. Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19. Rogosnitzky M; Okediji P; Koman I Pharmacol Rep; 2020 Dec; 72(6):1509-1516. PubMed ID: 32700247 [TBL] [Abstract][Full Text] [Related]
12. Cepharanthine inhibits proliferation of cancer cells by inducing apoptosis. Furusawa S; Wu J; Fujimura T; Nakano S; Nemoto S; Takayanagi M; Sasaki K; Takayanagi Y Methods Find Exp Clin Pharmacol; 1998 Mar; 20(2):87-97. PubMed ID: 9604850 [TBL] [Abstract][Full Text] [Related]
13. Role of the pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia. Brabers NA; Nottet HS Eur J Clin Invest; 2006 Jul; 36(7):447-58. PubMed ID: 16796601 [TBL] [Abstract][Full Text] [Related]
14. Cepharanthine inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing expression of vascular endothelial growth factor and interleukin-8. Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y Int J Oncol; 2009 Nov; 35(5):1025-35. PubMed ID: 19787256 [TBL] [Abstract][Full Text] [Related]
15. Ethanol extract from a Chinese herbal formula, "Zuojin Pill", inhibit the expression of inflammatory mediators in lipopolysaccharide-stimulated RAW 264.7 mouse macrophages. Wang QS; Cui YL; Dong TJ; Zhang XF; Lin KM J Ethnopharmacol; 2012 May; 141(1):377-85. PubMed ID: 22414473 [TBL] [Abstract][Full Text] [Related]
16. The prevention of lipopolysaccharide-induced pulmonary vascular injury by pretreatment with cepharanthine in rats. Murakami K; Okajima K; Uchiba M Am J Respir Crit Care Med; 2000 Jan; 161(1):57-63. PubMed ID: 10619798 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological Activity of Cepharanthine. Liu K; Hong B; Wang S; Lou F; You Y; Hu R; Shafqat A; Fan H; Tong Y Molecules; 2023 Jun; 28(13):. PubMed ID: 37446681 [TBL] [Abstract][Full Text] [Related]
18. Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages. Budai MM; Varga A; Milesz S; Tőzsér J; Benkő S Mol Immunol; 2013 Dec; 56(4):471-9. PubMed ID: 23911403 [TBL] [Abstract][Full Text] [Related]
19. Cepharanthine inhibits in vitro VSMC proliferation and migration and vascular inflammatory responses mediated by RAW264.7. Paudel KR; Karki R; Kim DW Toxicol In Vitro; 2016 Aug; 34():16-25. PubMed ID: 27021874 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of 12-O-tetradecanoyl phorbol-13-acetate promoted tumorigenesis by cepharanthine, a biscoclaurine alkaloid, in relation to the inhibitory effect on protein kinase C. Edashige K; Utsumi T; Utsumi K Biochem Pharmacol; 1991 Jan; 41(1):71-8. PubMed ID: 1986745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]